Skip to content

A Validation Study of the Neuro-cognitive Emotion Monitoring-Intervention (NEMO-I) Application in Adolescents

A Validation Study of the Neuro-cognitive Emotion Monitoring-Intervention (NEMO-I) Application in Adolescents

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07700264
Enrollment
140
Registered
2026-07-14
Start date
2026-07-10
Completion date
2027-04-30
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent - Emotional Problem, Adolescent Mental Health, Cognition Improvement

Keywords

Digital mental health intervention, adolescents, mobile based intervention, emotion, cognitive function, NEMO-I

Brief summary

This study aims to evaluate the validity and effectiveness of NEMO-I (Neuro-cognitive Emotion Monitoring-Intervention), a mobile application designed to help adolescents monitor and manage their cognitive and emotional functioning in everyday settings. NEMO-I delivers evidence-based psychological techniques-such as mindfulness, self-regulation training, and emotion monitoring-in a gamified format consisting of seven brief activities that users can complete at home in about 10 minutes each. A total of 140 middle and high school students will participate. Participants will complete standardized neuropsychological and psychological assessments before and after the intervention period. During the 21-day intervention period, participants will use the NEMO-I application at home each day at their convenience (a minimum of 10 minutes per day is recommended). By comparing pre- and post-intervention assessment results, this study seeks to determine whether the application produces meaningful benefits for adolescent mental health and to establish its suitability as a digital mental health tool.

Interventions

BEHAVIORALNEMO-I (Neuro-cognitive Emotion Monitoring-Intervention)

NEMO-I is a mobile application that delivers evidence-based psychological techniques in a gamified format. It consists of seven brief activities-including facial expression imitation, singing, breathing and stretching with nature sounds, reading tips for everyday concerns, rhythm-based instrument play, room decoration, and mindfulness-each designed to be completed at home in about 10 minutes. Participants use the application daily during the 21-day intervention period, at their convenience, with a recommended minimum of 10 minutes per day.

Sponsors

Seoul Women's University
Lead SponsorOTHER
Korea Health Industry Development Institute
CollaboratorOTHER_GOV
Ministry of Health & Welfare, Korea
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Middle or high school students currently enrolled in school * Using an Android-based smartphone * Voluntary agreement to participate, with consent from a legal guardian

Exclusion criteria

* Borderline intellectual functioning or intellectual disability (IQ below 80) * Visual or hearing impairment * Prior diagnosis of intellectual, visual, or hearing impairment

Design outcomes

Primary

MeasureTime frameDescription
Change in depressive symptomsBaseline (pre-intervention) and after the 21-day intervention periodDepressive symptoms are measured using the Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms. Change is assessed by comparing pre- and post-intervention scores.
Change in inhibitory control (Color-Word Stroop Test, CWST)Baseline(pre-intervention) and after the 21-day intervention periodInhibitory control is assessed using the Color-Word Stroop Test (CWST), which measures the efficiency of the frontal-lobe inhibition process. Performance is indexed by response time and error rate under the color-word interference condition. Change is assessed by comparing pre- and post-intervention performance.
Change in anxiety symptomsBaseline(pre-intervention) and after the 21-day intervention periodAnxiety symptoms are measured using the Beck Anxiety Inventory (BAI), a 21-item self-report questionnaire assessing the severity of anxiety-related symptoms. Higher scores indicate greater anxiety. Change is assessed by comparing pre- and post-intervention scores.
Change in neuro-cognitive and emotional function (NEMO-A)Baseline (pre-intervention) and after the 21-day intervention periodNeuro-cognitive and emotional function is assessed using the NEMO-A (Neuro-cognitive Emotion Monitoring-Assessment) application, a tablet-based, game-format assessment consisting of five subtasks. It measures domains including sustained attention, working memory, emotional sensitivity, emotion processing and recognition, audiovisual emotional integration, cognitive control, and executive function. Performance is indexed by accuracy and response time, and change is assessed by comparing pre- and post-intervention performance.
Change in visual attention and processing speed (Children's Color Trails Test, CCTT)Baseline (pre-intervention) and after the 21-day intervention periodVisual attention, psychomotor speed, sequential processing, and divided/sustained visual attention are assessed using the Children's Color Trails Test (CCTT). Performance is indexed by completion time (seconds). Change is assessed by comparing pre- and post-intervention performance.
Change in set-shifting ability (Trail Making Test-B, TMT-B)Baseline (pre-intervention) and after the 21-day intervention periodSet-shifting ability and cognitive flexibility are assessed using the Trail Making Test-B (TMT-B), which requires alternating between numbers and letters in sequence. Performance is indexed by completion time (seconds). Change is assessed by comparing pre- and post-intervention performance.

Secondary

MeasureTime frameDescription
Change in subjective stressBaseline (pre-intervention) and after the 21-day intervention periodSubjective stress is measured using a Visual Analog Scale (VAS), on which participants rate their current perceived stress level from 1 (no stress) to 10 (extreme stress).
Change in daily stressBaseline(pre-intervention) and after the 21-day intervention periodDaily stress is measured using a 26-item self-report scale assessing stress experienced in everyday domains such as parents, school, academics, peer relationships, appearance, and finances, rated on a 5-point Likert scale.
Change in alexithymiaBaseline (pre-intervention) and after the 21-day intervention periodDifficulty identifying and describing one's own emotions is measured using the Korean version of the 20-item Toronto Alexithymia Scale (TAS-20K), rated on a 5-point Likert scale.
Change in executive function difficulties (self-report)Baseline (pre-intervention) and after the 21-day intervention periodSelf-reported executive function difficulties are measured using the Brief Self-Report Questionnaire of Executive Function Difficulty for children and adolescents (40 items), rated on a 3-point Likert scale.
Change in peer relationship qualityBaseline (pre-intervention) and after the 21-day intervention periodThe quality of peer relationships is measured using a 13-item self-report scale rated on a 4-point Likert scale, including items reflecting conflict and negative peer interactions.
Change in problem behaviors (CBCL 6-18, parent report)Baseline (pre-intervention) and after the 21-day intervention periodProblem behaviors are assessed using the Child Behavior Checklist for Ages 6-18 (CBCL 6-18), completed by a parent or primary caregiver. It includes internalizing problems (e.g., anxiety, depression, somatic complaints) and externalizing problems (e.g., rule-breaking, aggressive behavior).
Change in ADHD symptoms (ARS, parent report)Baseline (pre-intervention) and after the 21-day intervention periodAttention-deficit/hyperactivity symptoms are assessed using the ADHD Rating Scale (ARS), an 18-item parent-report questionnaire comprising inattention and hyperactivity/impulsivity subscales.

Countries

South Korea

Contacts

CONTACTMyeongjie Im, MA
imj@swu.ac.kr+82-10-2588-0859
PRINCIPAL_INVESTIGATORHyunjoo Song, PhD

Seoul Women's University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026